Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Leufkens, Hubert GM"'
Autor:
Jadoenathmisier, Keerti D, Stoyanova-Beninska, Violeta, Soons, Inge M, Leufkens, Hubert GM, Bloem, Lourens T, Pasmooij, Anna MG
Publikováno v:
In European Journal of Pharmaceutical Sciences 1 November 2024 202
Autor:
Leung, Melissa Wy, Bazelier, Marloes T, Souverein, Patrick C, Uitdehaag, Bernard Mj, Klungel, Olaf H, Leufkens, Hubert Gm, Pajouheshnia, Romin, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Leung, M W Y, Bazelier, M T, Souverein, P C, Uitdehaag, B M J, Klungel, O H, Leufkens, H G M & Pajouheshnia, R 2022, ' Mapping the risk of infections in patients with multiple sclerosis : A multi-database study in the United Kingdom Clinical Practice Research Datalink GOLD and Aurum ', Multiple Sclerosis Journal, vol. 28, no. 11, pp. 1808-1818 . https://doi.org/10.1177/13524585221094218
Multiple Sclerosis Journal, 28(11), 1808-1818. SAGE Publications Ltd
Multiple sclerosis (Houndmills, Basingstoke, England), 28(11), 1808. SAGE Publications Ltd
Multiple Sclerosis Journal, 28(11), 1808-1818. SAGE Publications Ltd
Multiple sclerosis (Houndmills, Basingstoke, England), 28(11), 1808. SAGE Publications Ltd
Background: People with multiple sclerosis (pwMS) have an increased risk of infections; risk factors include underlying disease, physical impairment and use of some disease-modifying treatments. Objective: To quantify changes in population-level infe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42e7f4fa08bee00ee9014a0f056666d5
https://doi.org/10.1177/13524585221094218
https://doi.org/10.1177/13524585221094218
Autor:
Vreman, Rick A, Bloem, Lourens T, van Oirschot, Stijn, Hoekman, Jarno, van der Elst, Menno E, Leufkens, Hubert Gm, Klungel, Olaf H, Goettsch, Wim G, Mantel-Teeuwisse, Aukje K
BACKGROUND: The European Medicines Agency (EMA) aims to resolve uncertainties associated with conditionally approved drugs by imposing post-approval studies. Results from these studies may be relevant for health technology assessment (HTA) organizati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______101::951d347d1a013739b285a5a90b32290f
https://dspace.library.uu.nl/handle/1874/420563
https://dspace.library.uu.nl/handle/1874/420563
Autor:
Leung, Melissa WY, Bazelier, Marloes T, Souverein, Patrick C, Uitdehaag, Bernard MJ, Klungel, Olaf H, Leufkens, Hubert GM, Pajouheshnia, Romin
Supplemental material, sj-docx-1-msj-10.1177_13524585221094218 for Mapping the risk of infections in patients with multiple sclerosis: A multi-database study in the United Kingdom Clinical Practice Research Datalink GOLD and Aurum by Melissa WY Leung
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db479da164cfade050f97db581021829
Autor:
Leung, Melissa WY, Bazelier, Marloes T, Souverein, Patrick C, Uitdehaag, Bernard MJ, Klungel, Olaf H, Leufkens, Hubert GM, Pajouheshnia, Romin
Supplemental material, sj-docx-2-msj-10.1177_13524585221094218 for Mapping the risk of infections in patients with multiple sclerosis: A multi-database study in the United Kingdom Clinical Practice Research Datalink GOLD and Aurum by Melissa WY Leung
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6348b4b0f2c163a6214e8a373d92241
Autor:
Menckeberg, Tanja T, Belitser, Svetlana V, Bouvy, Marcel L, Bracke, Madelon, Lammers, Jan-Willem J, Raaijmakers, Jan AM, Leufkens, Hubert GM
Authors’ original file for figure 5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::668cf513e902f350e89c1e149c4fbeaf
Autor:
Menckeberg, Tanja T, Belitser, Svetlana V, Bouvy, Marcel L, Bracke, Madelon, Lammers, Jan-Willem J, Raaijmakers, Jan AM, Leufkens, Hubert GM
Additional File 1: Appendix Statistical description of the Markov model designed for the analysis of ICS use in this study. (DOC 41 KB)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37dc3f80e81a31c1697665f7ccffe178
Autor:
Menckeberg, Tanja T, Belitser, Svetlana V, Bouvy, Marcel L, Bracke, Madelon, Lammers, Jan-Willem J, Raaijmakers, Jan AM, Leufkens, Hubert GM
Authors’ original file for figure 6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afdf1f4e8da36141ad19a46fe2b12855
Autor:
Vreman, Rick A, Bloem, Lourens T, van Oirschot, Stijn, Hoekman, Jarno, van der Elst, Menno E, Leufkens, Hubert Gm, Klungel, Olaf H, Goettsch, Wim G, Mantel-Teeuwisse, Aukje K, Innovation Studies, Pharmacoepidemiology and Clinical Pharmacology, Afd Pharmacoepi & Clinical Pharmacology, Innovation and Sustainability
Publikováno v:
International Journal of Health Policy and Management, 11(5), 642. Kerman University of Medical Sciences
Background: The European Medicines Agency (EMA) aims to resolve uncertainties associated with conditionally approved drugs by imposing post-approval studies. Results from these studies may be relevant for health technology assessment (HTA) organizati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c76bb412f84022c076ef08a2155ad07
https://doi.org/10.34172/ijhpm.2020.198
https://doi.org/10.34172/ijhpm.2020.198
Autor:
Coppens, Delphi Gm, Gardarsdottir, Helga, van den Bogert, Cornelis A, De Bruin, Marie L, Leufkens, Hubert Gm, Hoekman, Jarno
Aim: We investigated publication rates and reported results for gene- and cell-based therapy trials. Materials & methods: In a cohort of Institutional Review Board (IRB)-authorized trials during 2007-2017 in the Netherlands (n = 105), we examine publ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______101::14b8ab52ec97ceeb4731f207ddfebd20
https://dspace.library.uu.nl/handle/1874/408024
https://dspace.library.uu.nl/handle/1874/408024